OKYO Pharma Limited (OKYO)
NASDAQ: OKYO
· Real-Time Price · USD
2.63
-0.01 (-0.38%)
At close: Aug 15, 2025, 3:59 PM
2.70
2.50%
After-hours: Aug 15, 2025, 06:35 PM EDT
OKYO Pharma Ratios and Metrics
Financials in USD. Fiscal
year is
April - March.
Fiscal Year | Q4 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
PE Ratio | n/a | -6.39K | -7.77K | n/a | n/a | -1.67K | -2.52K | -2.81K | -2.58 | -4.99K | -5.07 | -13.4K | -4.98 | -13.81K | -3.41 | -9.2K | -7.88 | -37.78K |
PEG Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 28.08 | -0.00 | 49.91 | -0.00 | 134.04 | -0.00 | 138.18 | -0.00 | 92.05 | -0.00 | 378.09 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | n/a | -4.74 | -5.76 | n/a | n/a | -14.35 | -18.71 | -25.72 | -164.6 | -146.77 | 19.80 | n/a | 10.26 | n/a | 7.18 | n/a | 5.19 | n/a |
P/FCF Ratio | n/a | -285.37K | -345K | n/a | n/a | -8.67K | -18.71K | -20.8K | -16.15 | -31.28K | -25.02 | -62.57K | -16.79 | -46.6K | -33.52 | -93.21K | -67.42 | -170.75K |
P/OCF Ratio | n/a | -285.37K | -345K | n/a | n/a | -8.67K | -18.73K | -20.82K | -16.16 | -31.31K | -25.04 | -62.61K | -16.79 | -46.6K | -33.66 | -93.61K | -67.65 | -171.35K |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | -0.00 | -0.00 | n/a | n/a | n/a | -1.08 | -1.08 | n/a | n/a | n/a | n/a | 0.02 | n/a | 0.02 | n/a | 0.00 | n/a |
Quick Ratio | 0.40 | 0.28 | 0.28 | 0.21 | n/a | n/a | 0.69 | 0.72 | 0.83 | 0.83 | 3.17 | n/a | 8.95 | n/a | 4.09 | n/a | 17.94 | n/a |
Current Ratio | 0.40 | 0.28 | 0.28 | 0.21 | n/a | n/a | 0.72 | 0.72 | 0.83 | 0.83 | 3.17 | n/a | 8.95 | n/a | 4.09 | n/a | 17.94 | n/a |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 15.98 | 0.01 | -0.98 | n/a | -0.52 | n/a | -0.53 | n/a | -0.16 | n/a |
Return on Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.11 | n/a | -0.67 | n/a | -0.45 | n/a | -0.39 | n/a | -0.16 | n/a |
Return on Invested Capital | n/a | n/a | n/a | n/a | n/a | n/a | 0.01 | n/a | 16.03 | 0.01 | -0.97 | n/a | -0.51 | n/a | -0.49 | n/a | -0.16 | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |